209 related articles for article (PubMed ID: 29016319)
21. Disseminated melioidosis presenting as septic arthritis.
Rajadhyaksha A; Sonawale A; Khare S; Kalal C; Jankar R
J Assoc Physicians India; 2012 Jun; 60():44-5. PubMed ID: 23409422
[TBL] [Abstract][Full Text] [Related]
22. Isolation rates of Burkholderia pseudomallei among the four regions in Thailand.
Leelarasamee A; Trakulsomboon S; Kusum M; Dejsirilert S
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):107-13. PubMed ID: 9322292
[TBL] [Abstract][Full Text] [Related]
23. Burkholderia pseudomallei endophthalmitis.
Chen KJ; Sun MH; Hou CH; Sun CC; Chen TL
J Clin Microbiol; 2007 Dec; 45(12):4073-4. PubMed ID: 17913931
[TBL] [Abstract][Full Text] [Related]
24. Ceftazidime resistance in Burkholderia pseudomallei: first report from India.
Behera B; Prasad Babu TL; Kamalesh A; Reddy G
Asian Pac J Trop Med; 2012 Apr; 5(4):329-30. PubMed ID: 22449529
[TBL] [Abstract][Full Text] [Related]
25. Variable presentation of neurological melioidosis in Northeast Thailand.
Limmathurotsakul D; Chaowagul W; Wongsrikaew P; Narmwong A; Day NP; Peacock SJ
Am J Trop Med Hyg; 2007 Jul; 77(1):118-20. PubMed ID: 17620641
[TBL] [Abstract][Full Text] [Related]
26. Melioidosis presenting as sepsis syndrome: a case report.
Redondo MC; Gómez M; Landaeta ME; Ríos H; Khalil R; Guevara RN; Palavecino S; Figuera M; Caldera J; Rivera R; Calvo A; Vitelli J; Morón M; Nuñez MJ
Int J Infect Dis; 2011 Mar; 15(3):e217-8. PubMed ID: 21195650
[TBL] [Abstract][Full Text] [Related]
27. Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model.
Trevino SR; Dankmeyer JL; Fetterer DP; Klimko CP; Raymond JLW; Moreau AM; Soffler C; Waag DM; Worsham PL; Amemiya K; Ruiz SI; Cote CK; Krakauer T
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009125. PubMed ID: 33571211
[TBL] [Abstract][Full Text] [Related]
28. Role and significance of quantitative urine cultures in diagnosis of melioidosis.
Limmathurotsakul D; Wuthiekanun V; Chierakul W; Cheng AC; Maharjan B; Chaowagul W; White NJ; Day NP; Peacock SJ
J Clin Microbiol; 2005 May; 43(5):2274-6. PubMed ID: 15872255
[TBL] [Abstract][Full Text] [Related]
29. A 5-year retrospective study of melioidosis cases treated in a district specialist hospital.
Tang RY; Lim SH; Lam JE; Nurasykin S; Eileen T; Chan YW
Med J Malaysia; 2019 Dec; 74(6):472-476. PubMed ID: 31929471
[TBL] [Abstract][Full Text] [Related]
30. Rheumatological manifestations in patients with melioidosis.
Teparrakkul P; Tsai JJ; Chierakul W; Gerstenmaier JF; Wacharaprechasgu T; Piyaphanee W; Limmathurotsakul D; Chaowagul W; Day NP; Peacock SJ
Southeast Asian J Trop Med Public Health; 2008 Jul; 39(4):649-55. PubMed ID: 19058601
[TBL] [Abstract][Full Text] [Related]
31. Mycotic aneurysm secondary to melioidosis in China: A series of eight cases and a review of literature.
Wu H; Wang X; Zhou X; Wu Z; Wang Y; Pan M; Lu B
PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008525. PubMed ID: 32785225
[TBL] [Abstract][Full Text] [Related]
32. Burkholderia pseudomallei: Challenges for the Clinical Microbiology Laboratory.
Hemarajata P; Baghdadi JD; Hoffman R; Humphries RM
J Clin Microbiol; 2016 Dec; 54(12):2866-2873. PubMed ID: 27654336
[TBL] [Abstract][Full Text] [Related]
33. Five-year surveillance for Burkholderia pseudomallei in Thailand from 2000 to 2004: prevalence and antimicrobial susceptibility.
Paveenkittiporn W; Apisarnthanarak A; Dejsirilert S; Trakulsomboon S; Thongmali O; Sawanpanyalert P; Aswapokee N
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S46-52. PubMed ID: 21298845
[TBL] [Abstract][Full Text] [Related]
34. In vitro motility of a population of clinical Burkholderia pseudomallei isolates.
Boonbumrung K; Wuthiekanun V; Rengpipat S; Day NP; Peacock SJ
J Med Assoc Thai; 2006 Sep; 89(9):1506-10. PubMed ID: 17100392
[TBL] [Abstract][Full Text] [Related]
35. Identification and Characterization of Burkholderia pseudomallei from Localized Pyogenic Infections in Eastern India: A Clinico-Microbiological Study.
Purushotham P; Mohanty S; Chappity P; Mishra TS; Mahapatra A
Am J Trop Med Hyg; 2021 Feb; 104(4):1252-1259. PubMed ID: 33534740
[TBL] [Abstract][Full Text] [Related]
36. Peritoneal Dialysis-Related Peritonitis Due to Melioidosis: A Potentially Devastating Condition.
Kanjanabuch T; Lumlertgul N; Pearson LJ; Chatsuwan T; Pongpirul K; Leelahavanichkul A; Thongbor N; Nuntawong G; Praderm L; Wechagama P; Narenpitak S; Wechpradit A; Punya W; Halue G; Naka P; Jeenapongsa S; Eiam-Ong S
Perit Dial Int; 2017; 37(2):183-190. PubMed ID: 27738086
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of bla(PenA) and bla(OXA) in Burkholderia pseudomallei Isolated from Patients at Sappasitthiprasong Hospital and Their Susceptibility to Ceftazidime and Carbapenems.
Panya M; Thirat S; Wanram S; Panomket P; Nilsakul J
J Med Assoc Thai; 2016 Jan; 99 Suppl 1():S12-6. PubMed ID: 26817233
[TBL] [Abstract][Full Text] [Related]
38. Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis.
Chierakul W; Anunnatsiri S; Short JM; Maharjan B; Mootsikapun P; Simpson AJ; Limmathurotsakul D; Cheng AC; Stepniewska K; Newton PN; Chaowagul W; White NJ; Peacock SJ; Day NP; Chetchotisakd P
Clin Infect Dis; 2005 Oct; 41(8):1105-13. PubMed ID: 16163628
[TBL] [Abstract][Full Text] [Related]
39. Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.
Sarovich DS; Price EP; Von Schulze AT; Cook JM; Mayo M; Watson LM; Richardson L; Seymour ML; Tuanyok A; Engelthaler DM; Pearson T; Peacock SJ; Currie BJ; Keim P; Wagner DM
PLoS One; 2012; 7(2):e30789. PubMed ID: 22363490
[TBL] [Abstract][Full Text] [Related]
40. Burkholderia pseudomallei peri-prosthetic infection following medial malleolar internal fixation: a case report.
Jayarajah U; Arulanantham A; Koculen V; Palkumbura C; Faleel A; Sooriyarachchi R
BMC Infect Dis; 2020 Mar; 20(1):236. PubMed ID: 32192457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
